Hemoperfusion as a Supportive Treatment in a COVID-19 Patient with Late Pulmonary Thromboembolism: A Case Report

Hemoperfusion as a Supportive Treatment in a COVID-19 Patient with Late Pulmonary Thromboembolism: A Case Report

Moradi H, Abbasi S

Hazhir Moradi,1 Saeed Abbasi2– 4 1Medical School, Isfahan University of Medical Sciences, Isfahan, Iran; 2Anesthesiology and Critical Care Research Center, Isfahan, Iran; 3Nosocomial Infection Research Center, Isfahan, Iran; 4Anesthesiology and Critical Care Department, Isfahan University of Medical Sciences, Isfahan, IranCorrespondence: Saeed AbbasiAnesthesiology and Critical Care Department, Isfahan University of Medical Sciences, Isfahan, IranTel +989131135730Email s_abbasi@med.mui.ac.irAbstract: In late 2019, the world encountered an unexpected new virus, resulting in a highly challenging new pandemic. The case presented here involves a 73-year-old man experiencing fever and respiratory distress, who was ultimately diagnosed with COVID-19. During the course of his hospitalization, the patient developed acute respiratory distress syndrome (ARDS), followed by being intubated due to his breathing difficulties. Because of variations in the patient’s clinical features, we decided to perform hemoperfusion to remove cytokines. Afterward, his clinical status improved significantly, and he was discharged in stable condition. However, 26 days later, fever and respiratory distress manifested again. After evaluation, pulmonary thromboembolism was confirmed through computed tomography (ie, CT scan).Keywords: COVID-19, hemoperfusion, acute respiratory distress syndrome, pulmonary thromboembolism

2020

covid-19, acute respiratory distress syndrome, pulmonary thromboembolism, hemoperfusion

Biotemas

Universidade Federal de Santa Catarina

Medicine (General)